GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Clicks Group Ltd (JSE:CLS) » Definitions » Retained Earnings

Clicks Group (JSE:CLS) Retained Earnings : R0 Mil (As of Feb. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Clicks Group Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Clicks Group's retained earnings for the quarter that ended in Feb. 2024 was R0 Mil.


Clicks Group Retained Earnings Historical Data

The historical data trend for Clicks Group's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clicks Group Retained Earnings Chart

Clicks Group Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Clicks Group Semi-Annual Data
Aug14 Feb15 Aug15 Feb16 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Clicks Group Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Clicks Group  (JSE:CLS) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Clicks Group (JSE:CLS) Business Description

Traded in Other Exchanges
Address
Cnr Searle and Pontac Streets, PO Box 5142, Cape Town, ZAF, 8001
Clicks Group Ltd operates pharmaceutical health and beauty retail stores. The company primarily operates a retail pharmacy chain in South Africa, with a limited number of operations in bordering countries. The company targets middle- to upper-income consumers. Clicks' business strategy focuses on consistent product sourcing, product development, and measured store expansion. The company has a portfolio of retail franchise brands including The Body Shop, GNC, and claire's. Clicks uses United Pharmaceutical Distributors' capabilities for the groups' integrated channel to the healthcare market.